
|Slideshows|February 27, 2018
Endo News Roundup for February 2018
Author(s)Mark L. Fuerst
Three new diabetes studies highlight one risk, one potential prevention, and one possible new treatment.
Advertisement
Three new diabetes studies highlight one risk, one potential prevention, and one possible new treatment. This short slide show highlights: -- The impact of night shift work on risk of T2DM -- A potential role for methyldopa to prevent T1DM onset -- Use of a ketone ester supplement to lower blood sugar levels
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Berobenatide Monthly Dosing Shows Weight Loss Efficacy in VESPER Trials, With John Buse, MD, PhD
5


























































